NJ panel is seeking ways to bring down costs in a dizzying world of rebates, generics, patents, pharmacy benefit managers and more
Katherine Hempstead
Katherine Hempstead is chair of the New Jersey Drug Affordability Council. She also is a senior policy officer for the Robert Wood Johnson Foundation. Previously she worked in state government and at Rutgers University.
Despite GOP actions to destabilize Affordable Care Act, the individual insurance market is doing well in Garden State. And new legislation in NJ is helping ...
The loss of two carriers hasn’t pushed up the cost of individual coverage in the Garden State, though that might be the expected outcome